Your browser version may not work well with NCBI's Web applications. More information here...
Items 1 - 20 of 98
of 5Next
1:

Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin.

Wang JY, Roehrl MH.

Med Immunol. 2005 Mar 24;4(1):4.

PMID: 15790405 [PubMed - as supplied by publisher]

2:

A dually active anthrax vaccine that confers protection against both bacilli and toxins.

Rhie GE, Roehrl MH, Mourez M, Collier RJ, Mekalanos JJ, Wang JY.

Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10925-30. Epub 2003 Sep 5.

PMID: 12960361 [PubMed - indexed for MEDLINE]

3:

Molecular basis for improved anthrax vaccines.

Brey RN.

Adv Drug Deliv Rev. 2005 Jun 17;57(9):1266-92. Epub 2005 Apr 21. Review.

PMID: 15935874 [PubMed - indexed for MEDLINE]

4:

Combining anthrax vaccine and therapy: a dominant-negative inhibitor of anthrax toxin is also a potent and safe immunogen for vaccines.

Aulinger BA, Roehrl MH, Mekalanos JJ, Collier RJ, Wang JY.

Infect Immun. 2005 Jun;73(6):3408-14.

PMID: 15908368 [PubMed - indexed for MEDLINE]

5:

The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.

Welkos S, Little S, Friedlander A, Fritz D, Fellows P.

Microbiology. 2001 Jun;147(Pt 6):1677-85.

PMID: 11390699 [PubMed - indexed for MEDLINE]

6:

Potential biological targets of Bacillus anthracis in anti-infective approaches against the threat of bioterrorism.

Bouzianas DG.

Expert Rev Anti Infect Ther. 2007 Aug;5(4):665-84. Review.

PMID: 17678429 [PubMed - indexed for MEDLINE]

7:

Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.

Enkhtuya J, Kawamoto K, Kobayashi Y, Uchida I, Rana N, Makino S.

Microbiology. 2006 Oct;152(Pt 10):3103-10.

PMID: 17005989 [PubMed - indexed for MEDLINE]

8:

Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.

Albrecht MT, Li H, Williamson ED, LeButt CS, Flick-Smith HC, Quinn CP, Westra H, Galloway D, Mateczun A, Goldman S, Groen H, Baillie LW.

Infect Immun. 2007 Nov;75(11):5425-33. Epub 2007 Jul 23.

PMID: 17646360 [PubMed - indexed for MEDLINE]

9:

A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.

Hermanson G, Whitlow V, Parker S, Tonsky K, Rusalov D, Ferrari M, Lalor P, Komai M, Mere R, Bell M, Brenneman K, Mateczun A, Evans T, Kaslow D, Galloway D, Hobart P.

Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13601-6. Epub 2004 Sep 1.

PMID: 15342913 [PubMed - indexed for MEDLINE]

10:

Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge.

Huang J, Mikszta JA, Ferriter MS, Jiang G, Harvey NG, Dyas B, Roy CJ, Ulrich RG, Sullivan VJ.

Hum Vaccin. 2007 May-Jun;3(3):90-3. Epub 2007 May 13.

PMID: 17375001 [PubMed - indexed for MEDLINE]

11:

Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.

Bielinska AU, Janczak KW, Landers JJ, Makidon P, Sower LE, Peterson JW, Baker JR Jr.

Infect Immun. 2007 Aug;75(8):4020-9. Epub 2007 May 14.

PMID: 17502384 [PubMed - indexed for MEDLINE]

12:

Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity.

Hashimoto M, Boyer JL, Hackett NR, Wilson JM, Crystal RG.

Infect Immun. 2005 Oct;73(10):6885-91.

PMID: 16177368 [PubMed - indexed for MEDLINE]

13:

Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen.

Duc le H, Hong HA, Atkins HS, Flick-Smith HC, Durrani Z, Rijpkema S, Titball RW, Cutting SM.

Vaccine. 2007 Jan 4;25(2):346-55. Epub 2006 Aug 4.

PMID: 17007969 [PubMed - indexed for MEDLINE]

14:

Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax.

Cohen S, Mendelson I, Altboum Z, Kobiler D, Elhanany E, Bino T, Leitner M, Inbar I, Rosenberg H, Gozes Y, Barak R, Fisher M, Kronman C, Velan B, Shafferman A.

Infect Immun. 2000 Aug;68(8):4549-58.

PMID: 10899854 [PubMed - indexed for MEDLINE]

16:

Past, imminent and future human medical countermeasures for anthrax.

Baillie LW.

J Appl Microbiol. 2006 Sep;101(3):594-606. Review.

PMID: 16907809 [PubMed - indexed for MEDLINE]

17:

Immunization studies with attenuated strains of Bacillus anthracis.

Ivins BE, Ezzell JW Jr, Jemski J, Hedlund KW, Ristroph JD, Leppla SH.

Infect Immun. 1986 May;52(2):454-8.

PMID: 3084383 [PubMed - indexed for MEDLINE]

18:

Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.

Stokes MG, Titball RW, Neeson BN, Galen JE, Walker NJ, Stagg AJ, Jenner DC, Thwaite JE, Nataro JP, Baillie LW, Atkins HS.

Infect Immun. 2007 Apr;75(4):1827-34. Epub 2006 Dec 4.

PMID: 17145938 [PubMed - indexed for MEDLINE]

19:

Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax.

Vietri NJ, Purcell BK, Lawler JV, Leffel EK, Rico P, Gamble CS, Twenhafel NA, Ivins BE, Heine HS, Sheeler R, Wright ME, Friedlander AM.

Proc Natl Acad Sci U S A. 2006 May 16;103(20):7813-6. Epub 2006 May 3.

PMID: 16672361 [PubMed - indexed for MEDLINE]

20:

DNA vaccination against anthrax in mice-combination of anti-spore and anti-toxin components.

Hahn UK, Boehm R, Beyer W.

Vaccine. 2006 May 22;24(21):4569-71. Epub 2005 Aug 24.

PMID: 16157424 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 98
of 5Next